FDA PMA FDA Class 3 Approved 🇺🇸 United States

Tricuspid Valve Repair Device, Percutaneously Delivered

PMA: P230007 · Supplement: S015 · Decision Aug 20, 2025
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P230007 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Tricuspid Valve Repair Device, Percutaneously Delivered
Trade Name
TriClip G5 Delivery System
PMA Number
P230007
Supplement Number
S015
Device Class
FDA Class 3
Product Code
NPS
Generic Name
Tricuspid valve repair device, percutaneously delivered
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
August 20, 2025
Date Received
July 21, 2025
Supplement Type
Special (Immediate Track)
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N

Advisory Committee Statement

Approval for updates to the Instructions for Use (IFU) to clarify information on several preparation steps for the MitraClip G5 and TriClip G5 Delivery Systems devices due to the design differences with the MitraClip G4 and TriClip G4 Delivery Systems.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NPS Tricuspid Valve Repair Device, Percutaneously Delivered